Corcept Therapeutics CORT Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's change in AP?
- Corcept Therapeutics (CORT) reported change in AP of -$7.64M in Q1 2026.
- How has Corcept Therapeutics's change in AP changed year-over-year?
- Corcept Therapeutics's change in AP decreased by 160.8% year-over-year, from $12.57M to -$7.64M.
- What does change in AP mean?
- The net change in money owed to suppliers for goods and services.
- How do you interpret change in AP?
- An increase suggests the company is delaying payments to preserve cash, while a decrease indicates faster settlement of obligations.
- How does change in AP compare across companies?
- Standard across all industries; peers typically show fluctuations based on procurement cycles.